Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
Abstract Background People with malignancy of undefined primary origin (MUO) have a poor prognosis and may undergo a protracted diagnostic workup causing patient distress and high cancer related costs. Not having a primary diagnosis limits timely site-specific treatment and access to precision medic...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-01-01
|
| Серія: | BMC Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12885-025-13506-4 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
